Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.218
Buy
RSI(14)
56.292
Neutral
STOCH(KDJ)(9,3,3)
39.648
Sell
ATR(14)
6.489
Low Volatility
CCI(14)
22.925
Neutral
Williams %R
37.653
Buy
TRIX(12,20)
0.356
Sell
StochRSI(14)
0.000
Oversold
Ascendis Pharma A/S
ASNDView Detailed Chart
170.800USD
-0.120-0.07%
Close 06/13, 16:00（ET）Quotes delayed by 15 min
10.41BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.07%
5 Days
-1.31%
1 Month
+8.65%
6 Months
+31.52%
Year to Date
+24.06%
1 Year
+33.81%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
17
analysts
BUY
Current Rating
223.750
Target Price
31.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
557
Total
5
Median
6
Average
Company name
Ratings
Analysts
Ascendis Pharma A/S
ASND
17
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
28
CRISPR Therapeutics AG
CRSP
28
Regeneron Pharmaceuticals Inc
REGN
28
Moderna Inc
MRNA
26
1
2
3
...
112
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Neutral
Moving Average
Indicators
Value
Direction
MA5
171.788
Sell
MA10
173.333
Sell
MA20
166.795
Buy
MA50
161.027
Buy
MA100
153.148
Buy
MA200
142.915
Buy
News
More news coming soon, stay tuned...
Company
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Ticker SymbolASND
CompanyAscendis Pharma A/S
CEOMr. Jan Moller Mikkelsen
Websitehttps://ascendispharma.dk/
Related Instruments
-0.32%
+1.42%
-1.51%
-1.42%
-2.50%
+1.57%
+1.91%
-1.88%
+0.07%
-0.97%
-0.45%
-11.34%
-2.49%
-0.59%
-0.91%
-1.89%
-0.20%
-1.96%
-5.54%
-1.26%
